SMT202000615T1 - Compressa con rivestimento enterico - Google Patents

Compressa con rivestimento enterico

Info

Publication number
SMT202000615T1
SMT202000615T1 SM20200615T SMT202000615T SMT202000615T1 SM T202000615 T1 SMT202000615 T1 SM T202000615T1 SM 20200615 T SM20200615 T SM 20200615T SM T202000615 T SMT202000615 T SM T202000615T SM T202000615 T1 SMT202000615 T1 SM T202000615T1
Authority
SM
San Marino
Prior art keywords
coated tablet
enteric coated
enteric
tablet
coated
Prior art date
Application number
SM20200615T
Other languages
English (en)
Inventor
Akio Ryu
Miyako Osada
Original Assignee
Zeria Pharm Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=51391349&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SMT202000615(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Zeria Pharm Co Ltd filed Critical Zeria Pharm Co Ltd
Publication of SMT202000615T1 publication Critical patent/SMT202000615T1/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/606—Salicylic acid; Derivatives thereof having amino groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SM20200615T 2013-02-22 2014-02-21 Compressa con rivestimento enterico SMT202000615T1 (it)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2013032759 2013-02-22
EP14754975.2A EP2959892B1 (en) 2013-02-22 2014-02-21 Enteric coated tablet
PCT/JP2014/054104 WO2014129568A1 (ja) 2013-02-22 2014-02-21 腸溶錠

Publications (1)

Publication Number Publication Date
SMT202000615T1 true SMT202000615T1 (it) 2021-01-05

Family

ID=51391349

Family Applications (1)

Application Number Title Priority Date Filing Date
SM20200615T SMT202000615T1 (it) 2013-02-22 2014-02-21 Compressa con rivestimento enterico

Country Status (26)

Country Link
US (5) US20150374632A1 (it)
EP (1) EP2959892B1 (it)
JP (1) JP6237760B2 (it)
KR (1) KR102167265B1 (it)
CN (1) CN105025888B (it)
AU (1) AU2014219726B2 (it)
BR (1) BR112015020237B1 (it)
CA (1) CA2901166C (it)
CY (1) CY1123908T1 (it)
DK (1) DK2959892T3 (it)
ES (1) ES2821766T3 (it)
HR (1) HRP20201808T1 (it)
HU (1) HUE052167T2 (it)
IL (1) IL240575B (it)
LT (1) LT2959892T (it)
MX (1) MX369967B (it)
NZ (1) NZ711201A (it)
PT (1) PT2959892T (it)
RS (1) RS61099B1 (it)
RU (1) RU2675844C2 (it)
SG (1) SG11201506653WA (it)
SI (1) SI2959892T1 (it)
SM (1) SMT202000615T1 (it)
TW (1) TWI688411B (it)
WO (1) WO2014129568A1 (it)
ZA (1) ZA201506585B (it)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107708696B (zh) 2015-06-30 2021-05-28 国立大学法人冈山大学 炎症性肠病的预防或治疗用药剂
EP3162362A1 (de) * 2015-10-30 2017-05-03 Dr. Falk Pharma Gmbh Optimierte mesalazinhaltige hochdosistablette
CN106511277A (zh) * 2016-11-22 2017-03-22 吉林省博大伟业制药有限公司 一种聚普瑞锌颗粒剂及其制备方法
US10098898B1 (en) 2017-12-04 2018-10-16 Handa Pharmaceuticals, Llc Release stable mesalamine dosage forms
EP3662898A1 (en) * 2018-12-07 2020-06-10 Tillotts Pharma AG Solid composition comprising mesalazine
TW202508608A (zh) * 2023-05-12 2025-03-01 南韓商法姆拜歐韓國股份有限公司 結腸緩瀉錠劑及包含彼之結腸緩瀉劑

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58109413A (ja) * 1981-12-23 1983-06-29 Eisai Co Ltd 耐衝撃性腸溶錠
US5914132A (en) 1993-02-26 1999-06-22 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
ITMI991316A1 (it) 1999-06-14 2000-12-14 Cip Ninety Two 92 S A Composizioni farmaceutiche orali a rilascio modificato di mesalazina
DE10013029A1 (de) * 2000-03-17 2001-09-20 Roehm Gmbh Mehrschichtige Arzneiform für die Colonfreigabe
US20020028240A1 (en) * 2000-04-17 2002-03-07 Toyohiro Sawada Timed-release compression-coated solid composition for oral administration
AU2002226955B2 (en) 2001-11-23 2006-04-27 Allergan Pharmaceuticals International Limited Pharmaceutical dosage form with multiple coatings
ES2645930T3 (es) * 2003-01-03 2017-12-11 Supernus Pharmaceuticals, Inc. Utilización de una mezcla de dos o más materiales entéricos para regular la liberación de fármacos a través de una membrana o matriz para terapias sistémicas
RU2375048C2 (ru) * 2003-07-17 2009-12-10 Д-Р Редди'С Лабораторис Инк. Фармацевтическая композиция с набухающим покрытием
MY147202A (en) 2003-11-26 2012-11-14 Novartis Ag Compositions comprising organic compounds
DE102006035549A1 (de) * 2006-07-27 2008-01-31 Evonik Röhm Gmbh Arzneiform mit mindestens zweischichtiger Trennschicht
PL2152250T3 (pl) * 2007-05-07 2020-06-15 Evonik Röhm Gmbh Stałe postaci dawkowania zawierające otoczkę dojelitową o przyspieszonym uwalnianiu leku
JP2011500553A (ja) * 2007-10-10 2011-01-06 ルピン・リミテッド 5−アミノサリチル酸またはその塩もしくは代謝産物の新規な結腸を標的とする調節放出性生体接着性製剤
US20090162434A1 (en) 2007-12-21 2009-06-25 Disphar International Bv Mesalazine tablet
US8329208B2 (en) * 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
CN101732280B (zh) * 2009-10-23 2012-04-18 天津力生制药股份有限公司 一种结肠定位释药的口服制剂
EP2425826A1 (en) * 2010-09-01 2012-03-07 Disphar International B.V. Mesalazine tablet having improved dissolution
EP2468264A1 (en) * 2010-12-27 2012-06-27 Laboratorios Liconsa, S.A. Oral pharmaceutical tablet for controled release of mesalazine and process for obtaining it
SI2659881T1 (en) * 2012-04-30 2018-03-30 Tillotts Pharma Ag Formulation of the delayed release medicinal product

Also Published As

Publication number Publication date
US20150374632A1 (en) 2015-12-31
CA2901166C (en) 2020-03-24
US20210093577A1 (en) 2021-04-01
CN105025888B (zh) 2018-10-12
BR112015020237B1 (pt) 2022-09-13
NZ711201A (en) 2019-10-25
WO2014129568A1 (ja) 2014-08-28
MX2015010871A (es) 2015-12-01
BR112015020237A2 (pt) 2017-07-18
SI2959892T1 (sl) 2020-12-31
HRP20201808T1 (hr) 2021-01-08
PT2959892T (pt) 2020-12-15
EP2959892A1 (en) 2015-12-30
US20250161222A1 (en) 2025-05-22
RU2675844C2 (ru) 2018-12-25
TWI688411B (zh) 2020-03-21
ZA201506585B (en) 2017-03-29
LT2959892T (lt) 2020-12-10
EP2959892B1 (en) 2020-09-09
CN105025888A (zh) 2015-11-04
CA2901166A1 (en) 2014-08-28
DK2959892T3 (da) 2020-09-21
IL240575A0 (en) 2015-09-24
RU2015140119A (ru) 2017-03-30
US20230372250A1 (en) 2023-11-23
KR20150118160A (ko) 2015-10-21
AU2014219726B2 (en) 2018-03-15
EP2959892A4 (en) 2016-10-05
HUE052167T2 (hu) 2021-04-28
RU2015140119A3 (it) 2018-03-06
TW201501731A (zh) 2015-01-16
JPWO2014129568A1 (ja) 2017-02-02
RS61099B1 (sr) 2020-12-31
JP6237760B2 (ja) 2017-11-29
SG11201506653WA (en) 2015-09-29
KR102167265B1 (ko) 2020-10-19
AU2014219726A1 (en) 2015-09-10
MX369967B (es) 2019-11-27
IL240575B (en) 2020-07-30
CY1123908T1 (el) 2022-03-24
US20190015345A1 (en) 2019-01-17
ES2821766T3 (es) 2021-04-27

Similar Documents

Publication Publication Date Title
DK3004155T3 (da) Peptidforbindelse
DK3342773T3 (da) Syk-hæmmere
UY4298S (es) Carcasa
DK3613453T3 (da) Fordamper
HUE036383T2 (hu) Bevonási eljárás
DOS2013000177S (es) Capsulas
DK2992104T3 (da) Fremgangsmåde til ekspression
DK3077047T3 (da) Aramcholsalte
DK3052081T3 (da) Pastil
DK3060460T3 (da) Saddel
PT3055308T (pt) Resumo
DK2956698T5 (da) Bindestrimler
DK3027598T3 (da) Oxoquinazolinyl-butanamidderivater
EP2982408A4 (en) INTERCONNECTS
DK3044389T3 (da) Vinduespost-tværstykke-konstruktion
EP2943489A4 (en) DEUTERATED MOMELOTINIB
FR3000700B1 (fr) Revetement anti-foudre
DK2946640T3 (da) Langmuir-probe
DE102013106534B8 (de) Chromatographiepipettenspitze
EP2991647A4 (en) DEUTERED AMLEXANOX
ZA201506585B (en) Enteric coated tablet
EP2970310A4 (en) 5-BROMO-indirubins
EP2853297A4 (en) kendama
DK3071227T3 (da) Fiskevaccine
EP2958828A4 (de) Spender